Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
24 06 2019
24 06 2019
Historique:
received:
13
06
2019
accepted:
13
06
2019
entrez:
26
6
2019
pubmed:
27
6
2019
medline:
27
6
2019
Statut:
epublish
Résumé
Following publication of the original article [1], the authors reported the following errors in the article.
Identifiants
pubmed: 31234810
doi: 10.1186/s12885-019-5831-x
pii: 10.1186/s12885-019-5831-x
pmc: PMC6591955
doi:
Types de publication
Journal Article
Published Erratum
Langues
eng
Pagination
620Commentaires et corrections
Type : ErratumFor
Références
BMC Cancer. 2019 May 30;19(1):517
pubmed: 31146717